Bioltas - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | - | - | - | 58,915 | 74,259 | 31,264 | 74,471 | 343,255 |
| Profit before tax | 0 | -29 | -31 | 17,154 | 3,974 | -18,033 | 4,418 | 55,697 |
| Net profit | 0 | -29 | -31 | 16,299 | 3,766 | -18,033 | 4,418 | 48,771 |
| Equity | 2,500 | 2,471 | 2,440 | 18,739 | 22,505 | 4,472 | 8,890 | 57,661 |
| Liabilities | 0 | 0 | 0 | 6,039 | 12,877 | 16,341 | 27,822 | 39,181 |
| Non-current assets | 0 | 0 | 0 | 4,597 | 3,375 | 1,478 | 3 | 16,392 |
| Current assets | 2,500 | 2,471 | 2,440 | 20,181 | 32,007 | 19,335 | 36,709 | 80,450 |
| Total assets | 2,500 | 2,471 | 2,440 | 24,778 | 35,382 | 20,813 | 36,712 | 96,842 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 786 | 2,343 | 6,632 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | - | - | - | +26.0% | -57.9% | +138.2% | +360.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.0% | -1.2% | -1.3% | 65.8% | 10.6% | -86.6% | 12.0% | 50.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 0.0% | -1.2% | -1.3% | 87.0% | 16.7% | -403.2% | 49.7% | 84.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | - | 27.7% | 5.1% | -57.7% | 5.9% | 14.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | 29.1% | 5.4% | -57.7% | 5.9% | 16.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | 0.3 | 0.6 | 3.7 | 3.1 | 0.7 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | 58,915 | 74,259 | 31,264 | 68,745 | 343,255 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Bioltas - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-07-16 | 2025-07-16 | 109.93 |
| 2023-10-17 | 2023-11-14 | 0.02 |
| 2023-09-18 | 2023-10-11 | 0.02 |
| 2023-08-17 | 2023-09-10 | 0.02 |
| 2023-07-24 | 2023-08-07 | 0.02 |
| 2023-06-16 | 2023-06-21 | 28.04 |
| 2022-02-17 | 2022-03-02 | 0.04 |
| 2022-01-31 | 2022-02-13 | 0.04 |
| 2021-10-18 | 2021-10-19 | 23.40 |
Bioltas - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-03-29 | 2026-03-30 | 0.41 |
| 2026-03-08 | 2026-03-11 | 379.03 |
| 2026-03-02 | 2026-03-07 | 378.53 |
| 2025-11-28 | 2025-12-22 | 2.03 |
| 2025-11-02 | 2025-11-18 | 2.03 |
| 2025-10-24 | 2025-10-26 | 125.4 |
| 2024-10-01 | 2024-10-16 | 3.41 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Bioltas, UAB (code 304697247) is a Private Limited Liability Company engaged in materials recovery. In the latest financial year, 2025, the company generated revenue of €343.3K and net profit of €48.8K, which corresponded to a profit margin of 14.2%. Performance improved sharply over the last three years: revenue increased from €31.3K in 2023 to €74.5K in 2024 and then to €343.3K in 2025, while net profit moved from a loss of €18.0K in 2023 to a profit of €4.4K in 2024 and €48.8K in 2025. Balance sheet indicators also strengthened. At the end of 2025, total assets stood at €96.8K, equity at €57.7K and liabilities at €39.2K, with an equity ratio of 59.5% and debt-to-equity of 0.68. Asset turnover was 3.54x, indicating efficient use of assets. Based on the available staff-related metric, revenue per employee was €343.3K and profit per employee was €48.8K in 2025.